Cargando…
Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk
Prostate cancer is the most frequent and second most lethal cancer in men in the United States. Innate immunity and inflammation may increase the risk of prostate cancer. To determine the role of innate immunity and inflammation in advanced prostate cancer, we investigated the association of 320 sin...
Autores principales: | Kazma, Rémi, Mefford, Joel A., Cheng, Iona, Plummer, Sarah J., Levin, Albert M., Rybicki, Benjamin A., Casey, Graham, Witte, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522730/ https://www.ncbi.nlm.nih.gov/pubmed/23272139 http://dx.doi.org/10.1371/journal.pone.0051680 |
Ejemplares similares
-
Use of principal components to aggregate rare variants in case-control and family-based association studies in the presence of multiple covariates
por: Kazma, Rémi, et al.
Publicado: (2011) -
COX2 genetic variation, NSAIDs, and advanced prostate cancer risk
por: Cheng, I, et al.
Publicado: (2007) -
Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer
por: Reese, Adam C., et al.
Publicado: (2010) -
Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer
por: Ross, Phillip L, et al.
Publicado: (2009) -
The Covariate's Dilemma
por: Mefford, Joel, et al.
Publicado: (2012)